Abstract
Introduction: Lithium carbonate is the gold-standard mood stabilizer for the treatment of bipolar disorder (BD). However, its use may be associated with adverse events that can compromise treatment adherence and patient safety. In this context, Anvisa's spontaneous adverse event reporting system (VigiMed) is a relevant pharmacovigilance tool for identifying potential safety signals. Moreo…